Cerbomed GmbH is an innovative medical device company located in Erlangen, Germany, that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses.
The transcutaneous Vagus Nerve Stimulation received the European clearance (CE mark) for the treatment of epilepsies, depression and pain. Two clinical studies regarding the effectiveness of t-VNS in patients with drug-resistant epilepsy and chronic migraine have been successfully finished.
NEMOS® is a neurostimulation device that is used for therapy against epilepsy. The VITOS® device is used for therapy against pain and depression.
Please note: NEMOS® and VITOS® are not cleared or approved for use in the U.S.